Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B KABAKOW

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
National Cancer Institute Monograph|October 1, 1975
Current status of the second-look operation in ovarian carcinomaR C Wallach, B Kabakow, G Blinick
JAMA|November 28, 1980
A novel approach to the temporary control of intractable bone painJ I Zweig, L Malspies, S Kaur, et al.
Urology|May 1, 1987
Breast carcinoma metastatic to bladderL I Silverstein, L Plaine, J E Davis, et al.
Radiology|March 1, 1975
The adjuvant effect of lucanthone (miracil D) in clinical radiation therapyS Turner, R Bases, A Pearlman, et al.
Obstetrics and Gynecology|March 1, 1980
Chemotherapy of recurrent ovarian carcinoma with cis-dichlorodiammine platinum II and adriamycinR C Wallach, C Cohen, H Bruckner, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
Obstetrics and Gynecology|January 1, 1987
Prognostic factors: cisplatin regimens for patients with ovarian cancer after failure of chemotherapyH W Bruckner, C J Cohen, E Feuer, et al.
Acta Haematologica|January 1, 1985
Philadelphia-chromosome-negative chronic myelogenous leukemia with incomplete trisomy 1q following chemotherapy for ovarian carcinomaA Haubenstock, R Zalusky, H J Kim, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapyH W Bruckner, L H Ratner, C J Cohen, et al.
Cancer Treatment Reports|April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapyH W Bruckner, C J Cohen, R C Wallach, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
National Cancer Institute Monograph|October 1, 1975
Current status of the second-look operation in ovarian carcinomaR C Wallach, B Kabakow, G Blinick
JAMA|November 28, 1980
A novel approach to the temporary control of intractable bone painJ I Zweig, L Malspies, S Kaur, et al.
Urology|May 1, 1987
Breast carcinoma metastatic to bladderL I Silverstein, L Plaine, J E Davis, et al.
Radiology|March 1, 1975
The adjuvant effect of lucanthone (miracil D) in clinical radiation therapyS Turner, R Bases, A Pearlman, et al.
Obstetrics and Gynecology|March 1, 1980
Chemotherapy of recurrent ovarian carcinoma with cis-dichlorodiammine platinum II and adriamycinR C Wallach, C Cohen, H Bruckner, et al.
Cancer Treatment Reviews|March 1, 1991
Hexamethylmelamine for the treatment of ovarian cancer--the Mount Sinai experienceH W Bruckner, C Cohen, J Mandeli, et al.
Obstetrics and Gynecology|January 1, 1987
Prognostic factors: cisplatin regimens for patients with ovarian cancer after failure of chemotherapyH W Bruckner, C J Cohen, E Feuer, et al.
Acta Haematologica|January 1, 1985
Philadelphia-chromosome-negative chronic myelogenous leukemia with incomplete trisomy 1q following chemotherapy for ovarian carcinomaA Haubenstock, R Zalusky, H J Kim, et al.
Cancer Treatment Reports|July 1, 1978
Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapyH W Bruckner, L H Ratner, C J Cohen, et al.
Cancer Treatment Reports|April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapyH W Bruckner, C J Cohen, R C Wallach, et al.
Pageof 2